Delivery Order SPE2DB24D1205-SPE2DB25FCYDB
- Not listed
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, a specialty medication used in the treatment of eye conditions. The contract has a ceiling value of $2,652.78 and an ultimate completion date of June 14, 2024. The contract is a Firm Fixed Price type, with no set-aside designation....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a prescription eye medication. The contract is a firm fixed-price delivery order with a ceiling value of $2,136.66 and a period of performance through July 9, 2025. The contract is not designated as a set-aside and represents open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a prescription medication, with a ceiling value of $6,278.02. The contract is a firm fixed-price delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract, which is a firm fixed-price delivery order, has a ceiling value of $1,465.16 and a completion date of July 10, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, a prescription medication, with a ceiling value of $2,741.60 and a period of performance through June 24, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a prescription eye medication, with a ceiling value of $3,729.72 and a period of performance through June 2025. The contract is not set aside and is a firm fixed price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a ceiling value of $1,161.69 and a performance period ending on June 13, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a critical ophthalmic medication, to support military treatment facilities and other government healthcare programs. The contract has a firm fixed price of $2,991.65 and runs through September 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,990.61, is for the delivery of Cyclosporine 0.05% eye emulsion, a medication used to treat various eye conditions. The contract is a firm fixed-price type with a period of performance through March 22, 2023. It is not designated as a set-aside contract, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract has a ceiling value of $4,820.52 and is a firm fixed-price delivery order, with a period of performance through December 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYDBDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a medication used to treat eye conditions. The contract is a firm fixed-price delivery order with a ceiling value of $12,170.78 and a period of performance through July 1, 2025. The contract is not set aside for any small business program. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows for multiple delivery orders across different therapeutic categories, positioning AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 6/30/25 |